Trump rolls back effort to lower Medicare, Medicaid drug costs
Read more at MarketWatch
-
Trump rolls back Biden directive to study methods of lowering prescription costs
Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for ...The Hill - 7h -
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...The Hill - 4d -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 4d -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - 4d -
Two Watchdogs Were Rebuffed From Joining Trump’s Cost-Cutting Effort
“We have no room in our administration for Democrats,” a transition spokeswoman replied after good-government activists tried to join the president-elect’s new efficiency department.The New York Times - 5d -
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.CNBC - 5d -
Corrective action is needed to preserve Social Security, Medicare and Medicaid
Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and Medicaid.The Hill - Jan. 10 -
EU fears Trump rolling back Biden-era measures
Bloc concerned about president-elect reversing US sanctions against Russia and other policiesFinancial Times - Jan. 10 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9
More from MarketWatch
-
Tesla’s ‘Trump bump’ fades as stock falls alongside rest of EV sector
Investors still expect Musk to benefit more broadly from Trump 2.0.MarketWatch - 3h -
United Airlines stock rallies on results, as growing demand wasn’t just about premium seats
Shares of United Airlines rallied in after-hours trading Tuesday, as a record number of travelers lifted fourth-quarter results and the company offered an upbeat forecast for the first quarter.MarketWatch - 4h -
Netflix’s stock surges as huge subscriber beat goes beyond traction with sports
Analysts predicted live sports might power a Netflix subscriber beat. But as the company trounced the expectations, management said sports drove only a “small minority” of additions.MarketWatch - 4h -
The rich and famous don’t fear a stock market bubble. That’s why you should.
Elites at Davos believe ‘asset bubble bursts’ is a low risk over the next two years.MarketWatch - 5h -
Netflix is raising prices. Here’s how much more your plan will cost.
Netflix is raising the price of its standard ad-free plan for the first time in three years, though it will still cost less than the comparable version of Hulu,MarketWatch - 5h
More in Business
-
Kevin O'Leary says he would 'love to do a TikTok deal,' but the law prevents it
Kevin O’Leary says that he’s still interested in a deal for TikTok, but that it’s no longer legally viable, even after Trump extended a ban on the platform.CNBC - 37m -
Trump halts more than $300bn in US green infrastructure funding
New president’s order to pause federal disbursements cuts critical loans and grants to developersFinancial Times - 46m -
Trump vs the ‘deep state’: the vendetta agenda takes shape
The US president is already coming good on his promise to go after his enemiesFinancial Times - 46m -
Google invests further $1bn in OpenAI rival Anthropic
Artificial intelligence group closes in on $60bn valuationFinancial Times - 47m -
China’s hopes grow for deal to avert trade war with Trump
New US president hints at potential agreement linking TikTok ownership with tariffsFinancial Times - 47m